FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
Go back to FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 54.63 -0.52 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.15 | 52 Week High | $35.13 | |||
| Open | $54.46 | 52 Week Low | $28.10 | |||
| Day High | $54.99 | P/E | N/A | |||
| Day Low | $54.43 | EPS | $0.00 | |||
| Volume | 1,225,786 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
| Roper Industries (NASDAQ: ROP) | Delayed: 374.76 -1.06 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $375.82 | 52 Week High | $195.93 | |||
| Open | $374.93 | 52 Week Low | $155.79 | |||
| Day High | $377.21 | P/E | 69.79 | |||
| Day Low | $370.52 | EPS | $5.37 | |||
| Volume | 659,819 | |||||
